427 related articles for article (PubMed ID: 32296020)
1. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.
Gao L; Zhong X; Jin J; Li J; Meng XM
Signal Transduct Target Ther; 2020 Feb; 5(1):9. PubMed ID: 32296020
[TBL] [Abstract][Full Text] [Related]
2. Acute Kidney Injury to Chronic Kidney Disease Transition.
Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
[TBL] [Abstract][Full Text] [Related]
3. Non-coding RNAs in kidney injury and repair.
Liu Z; Wang Y; Shu S; Cai J; Tang C; Dong Z
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C177-C188. PubMed ID: 30969781
[TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor-β in the Acute Kidney Injury to Chronic Kidney Disease Transition.
Gewin LS
Nephron; 2019; 143(3):154-157. PubMed ID: 31039574
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
Nangaku M; Hirakawa Y; Mimura I; Inagi R; Tanaka T
Nephron; 2017; 137(4):256-259. PubMed ID: 28595179
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the transition of acute kidney injury to chronic kidney disease: Potential mechanisms and future perspectives.
Ogbadu J; Singh G; Aggarwal D
Eur J Pharmacol; 2019 Dec; 865():172711. PubMed ID: 31589870
[TBL] [Abstract][Full Text] [Related]
7. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.
He L; Wei Q; Liu J; Yi M; Liu Y; Liu H; Sun L; Peng Y; Liu F; Venkatachalam MA; Dong Z
Kidney Int; 2017 Nov; 92(5):1071-1083. PubMed ID: 28890325
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Modification Drives Acute Kidney Injury-to-Chronic Kidney Disease Progression.
Li Z; Li N
Nephron; 2021; 145(6):737-747. PubMed ID: 34419948
[TBL] [Abstract][Full Text] [Related]
9. Role of endoplasmic reticulum stress and autophagy in the transition from acute kidney injury to chronic kidney disease.
Habshi T; Shelke V; Kale A; Anders HJ; Gaikwad AB
J Cell Physiol; 2023 Jan; 238(1):82-93. PubMed ID: 36409755
[TBL] [Abstract][Full Text] [Related]
10. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease.
Inoue T; Kusano T; Amano H; Nakamoto H; Okada H
Biochem Biophys Res Commun; 2019 Sep; 517(1):96-102. PubMed ID: 31320136
[TBL] [Abstract][Full Text] [Related]
11. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
[TBL] [Abstract][Full Text] [Related]
12. FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling.
Li ZL; Wang B; Lv LL; Tang TT; Wen Y; Cao JY; Zhu XX; Feng ST; Crowley SD; Liu BC
Acta Pharmacol Sin; 2021 Dec; 42(12):2106-2119. PubMed ID: 33658705
[TBL] [Abstract][Full Text] [Related]
13. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage.
Franzin R; Stasi A; Fiorentino M; Stallone G; Cantaluppi V; Gesualdo L; Castellano G
Front Immunol; 2020; 11():734. PubMed ID: 32457738
[TBL] [Abstract][Full Text] [Related]
14. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
[TBL] [Abstract][Full Text] [Related]
15. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
16. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
Zhang X; Agborbesong E; Li X
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
[TBL] [Abstract][Full Text] [Related]
17. Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure.
Tan HL; Yap JQ; Qian Q
Blood Purif; 2016; 41(1-3):144-50. PubMed ID: 26764483
[TBL] [Abstract][Full Text] [Related]
18. Upregulated miR-101 inhibits acute kidney injury-chronic kidney disease transition by regulating epithelial-mesenchymal transition.
Zhao JY; Wang XL; Yang YC; Zhang B; Wu YB
Hum Exp Toxicol; 2020 Dec; 39(12):1628-1638. PubMed ID: 32633566
[TBL] [Abstract][Full Text] [Related]
19. Role of SIK1 in the transition of acute kidney injury into chronic kidney disease.
Hu J; Qiao J; Yu Q; Liu B; Zhen J; Liu Y; Ma Q; Li Y; Wang Q; Wang C; Lv Z
J Transl Med; 2021 Feb; 19(1):69. PubMed ID: 33588892
[TBL] [Abstract][Full Text] [Related]
20. Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure.
Su H; Ye C; Lei CT; Tang H; Zeng JY; Yi F; Zhang C
FASEB J; 2020 Jan; 34(1):1620-1636. PubMed ID: 31914692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
